IMN || FDA & CDC

FDA approves Viberzi and Xifaxan for IBS

Posted on: 28/05/2015 - 18:42

The Food and Drug Administration has approved Viberzi (eluxadoline) and Xifaxan (rifaximin) to treat irritable bowel syndrome with diarrhea (IBS-D) in adults, the agency announced May 27. Viberzi is...

Field of Interest: Gastroentero...

Type: News Item

CDC: LARC should be preferred contraceptive method for sexually active teens

Posted on: 07/04/2015 - 20:18

Despite birth rates among American teenagers continuing to decrease in recent years, not enough sexually active teens know of and use LARC, which the ... More »

Field of Interest: Pulmonology

Type: News Item

Manufacturer releases new reprocessing instructions for TJF-Q180V duodenoscope

Posted on: 27/03/2015 - 20:22

Olympus, the manufacturer of the TJF-Q180V duodenoscope, has issued new, validated instructions for reprocessing this particular model, as part of the... More »

Field of Interest: Gastroentero...

Type: News Item

ACIP votes on incorporating 9-valent HPV vaccine into recommendations

Posted on: 27/02/2015 - 16:17

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to support proposed recommendations for use of t... More »

Field of Interest: Pulmonology

Type: News Item

Difficult-to-clean ERCP duodenoscopes linked to serious infections

Posted on: 20/02/2015 - 14:12

The Food and Drug Administration is alerting health care professionals and the public about the association with duodenoscopes and the transmission of... More »

Field of Interest: Gastroentero...

Type: News Item

VIDEO: As biosimilars arrive in U.S., treatment questions arise

Posted on: 18/02/2015 - 21:44

MAUI, HAWAII – There’s been fairly brisk uptake of biosimilar infliximab in Europe, both for new patients and as a possible switch from Remicade. ... More »

Field of Interest: Rheumatology

Type: News Item

VIDEO: As biosimilars arrive in U.S., treatment questions arise

Posted on: 18/02/2015 - 21:44

MAUI, HAWAII – There’s been fairly brisk uptake of biosimilar infliximab in Europe, both for new patients and as a possible switch from Remicade. ... More »

Field of Interest: Dermatology

Type: News Item

FDA allows marketing of vaginally inserted device for fecal incontinence

Posted on: 13/02/2015 - 18:32

A vaginally inserted device that uses a balloon inflated by the patient to occlude the rectum has been cleared for marketing as a treatment for fecal ... More »

Field of Interest: Gastroentero...

Type: News Item

FDA allows marketing of vaginally inserted device for fecal incontinence

Posted on: 13/02/2015 - 18:32

A vaginally inserted device that uses a balloon inflated by the patient to occlude the rectum has been cleared for marketing as a treatment for fecal ... More »

Field of Interest: Pulmonology

Type: News Item

Dermal filler approved for treating acne scars

Posted on: 09/02/2015 - 19:07

A collagen dermal filler already on the market has been approved for improving the appearance of acne scars in people aged 21 years and older. The f... More »

Field of Interest: Dermatology

Type: News Item

FDA approves Viberzi and Xifaxan for IBS

CDC: LARC should be preferred contraceptive method for sexually active teens

Manufacturer releases new reprocessing instructions for TJF-Q180V duodenoscope

ACIP votes on incorporating 9-valent HPV vaccine into recommendations

Difficult-to-clean ERCP duodenoscopes linked to serious infections

VIDEO: As biosimilars arrive in U.S., treatment questions arise

VIDEO: As biosimilars arrive in U.S., treatment questions arise

FDA allows marketing of vaginally inserted device for fecal incontinence

FDA allows marketing of vaginally inserted device for fecal incontinence

Dermal filler approved for treating acne scars

Newsletters

Latest Newsletters

You are here

IMN || FDA & CDC

Newsletters

Latest Newsletters